04045oam 2200805I 450 991078137330332120230725051736.01-136-65988-91-283-10303-697866131030311-136-65989-70-203-80707-310.4324/9780203807071 (CKB)2550000000032736(EBL)683991(OCoLC)721907177(SSID)ssj0000535124(PQKBManifestationID)11359078(PQKBTitleCode)TC0000535124(PQKBWorkID)10522216(PQKB)11712385(MiAaPQ)EBC683991(Au-PeEL)EBL683991(CaPaEBR)ebr10466412(CaONFJC)MIL310303(OCoLC)779171523(EXLCZ)99255000000003273620180706e20112009 uy 0engur|n|---|||||txtccrClose to the sources essays on contemporary African culture, politics and academy /Abebe Zegeye, Maurice VambeNew York :Routledge,2011.1 online resource (181 p.)Routledge African studies ;5"First published in paperback 2009 by Unisa Press, University of South Africa"--T.p. verso."Simultaneously published in the UK"--T.p. verso.1-138-09258-4 0-415-89595-2 Includes bibliographical references (p. 157-168) and index.Front Cover; Close to the Sources; Copyright Page; Contents; Acknowledgements; Chapter One. Introduction: The Assault on African Cultures; Chapter Two. Notes on Theorising Black Diaspora in Africa; Chapter Three. On the Postcolony and the Vulgarisation of Political Criticism; Chapter Four. Rethinking the Epistemic Conditions of Genocide in Africa; Chapter Five. African Indigenous Knowledge Systems; Chapter Six. Knowledge Production and Publishing in Africa; Chapter Seven. Amilcar Cabral: National Liberation as the Basis of Africa's RenaissancesChapter Eight. Amilcar Cabral and the Fortunes of African LiteratureChapter Nine. Perspectives on Africanising Educational Curricula in Africa; Chapter Ten. Voices from the Fringes: Some Reflections on Postcolonial South African Writings; Bibliography; IndexEuropean and African works have found it difficult to move past the image of Africa as a place of exotica and relentless brutality. This book explores the status and critical relationship between politics, culture, literary creativity, criticism, education and publishing in the context of promoting Africa's indigenous knowledge, and seeks to recover some of the sites where Africans continue to elaborate conflicting politics of self-affirmations. It both acknowledges and steps outside the protocols of analysis informed by nationalism, differentiating the forms that postcolonial theories haveRoutledge African studies ;5.PostcolonialismAfricaEducationAfricaHistory20th centuryEducationAfricaHistory21st centuryAfrican literature20th centuryHistory and criticismAfrican literature21st centuryHistory and criticismAfricaCivilization20th centuryAfricaCivilization21st centuryAfricaPolitics and government1960-AfricaIntellectual lifePostcolonialismEducationHistoryEducationHistoryAfrican literatureHistory and criticism.African literatureHistory and criticism.960.3/2Zegeye Abebe.285185Vambe Maurice Taonezvi696164MiAaPQMiAaPQMiAaPQBOOK9910781373303321Close to the sources3721557UNINA04839nam 2200541 450 991081181770332120230803205625.00-309-30669-80-309-30667-1(CKB)3710000000260769(MiAaPQ)EBC3379386(Au-PeEL)EBL3379386(CaPaEBR)ebr10951340(OCoLC)883575949(EXLCZ)99371000000026076920141017h20142014 uy 0engurcnu||||||||rdacontentrdamediardacarrierContemporary issues for protecting patients in cancer research workshop summary /Institute of Medicine (U.S.) ; Sharyl J. Nass and Margie Patlak, Rapporteurs National Cancer Policy Forum Board on Health Care ServicesWashington, District of Columbia :National Academies Press,2014.©20141 online resource (92 pages) illustrations0-309-30674-4 0-309-30666-3 Introduction -- Current regulatory arena -- Common rule and HIPAA -- Shortcomings of current regulations and guidances -- Context -- Data deindentification -- Impediment to quality improvement and learning -- Varied interpretation -- Misaligned incentives -- Lack of harmonization with international standards -- Informed consent forms -- Informed consent process -- Consent tools -- Beyond consent -- HITECH -- Advanced notice of proposed rulemaking -- Patient perspectives on research protections -- Ethical challenges of genetic advances -- Patient consent for use of archived biospecimens -- Return of research results -- Clinically actionable findings -- Context matters -- Who pays -- Biospecimens from deceased participants -- The changing context of research and care -- Oversight in a learning health care system -- Oversight of pragmatic trials -- Multisite studies and IRB review -- Central IRBs -- New England Reliance Agreement -- Value of local IRBs -- Educational needs -- Research needs -- Wrap-up."In the nearly 40 years since implementation of federal regulations governing the protection of human participants in research, the number of clinical studies has grown exponentially. These studies have become more complex, with multisite trials now common, and there is increasing use of archived biospecimens and related data, including genomics data. In addition, growing emphasis on targeted cancer therapies requires greater collaboration and sharing of research data to ensure that rare patient subsets are adequately represented. Electronic records enable more extensive data collection and mining, but also raise concerns about the potential for inappropriate or unauthorized use of data, bringing patient protections into a new landscape. There are also long-standing concerns about the processes and forms used to obtain informed consent from patients participating in clinical studies. These changes and challenges raise new ethical and practical questions for the oversight of clinical studies, and for protecting patients and their health information in an efficient manner that does not compromise the progress of biomedical research. Contemporary Issues for Protecting Patients in Cancer Research is the summary of a workshop convened by the National Cancer Policy Forum of the Institute of Medicine in February 2014 to explore contemporary issues in human subjects protections as they pertain to cancer research, with the goal of identifying potential relevant policy actions. Clinical researchers, government officials, members of Institutional Review Boards, and patient advocates met to discuss clinical cancer research and oversight. This report examines current regulatory provisions that may not adequately protect patients or may be hindering research, and discusses potential strategies and actions to address those challenges"--Publisher's description.Human experimentation in medicineUnited StatesHuman experimentation in medicineMoral and ethical aspectsUnited StatesPatientsCivil rightsUnited StatesHuman experimentation in medicineHuman experimentation in medicineMoral and ethical aspectsPatientsCivil rights174.28Nass Sharyl J.857626Nass Sharyl J.Patlak MargieNational Cancer Policy Forum (U.S.),Contemporary Issues in Human Subjects Protections (Workshop)(2014 :Washington, D.C.)MiAaPQMiAaPQMiAaPQBOOK9910811817703321Contemporary issues for protecting patients in cancer research4038964UNINA